Join to view full profile
3 Crossing BlvdSte 1Clifton Park, NY 12065
Phone+1 518-831-4434
Fax+1 518-831-4435
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Howard Schlossberg, MD is an oncologist in Clifton Park, New York. He is currently licensed to practice medicine in New York, Pennsylvania, and Pennsylvania.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2002 - 2005
Temple University HospitalResidency, Internal Medicine, 1999 - 2002
Lewis Katz School of Medicine at Temple UniversityClass of 1999
Certifications & Licensure
NY State Medical License 2005 - 2028
PA State Medical License 2000 - 2016- PA State Medical License 2000 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed™ EHR, US Oncology, 2012, 2014-2017
Publications & Presentations
PubMed
- 34 citationsRandomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage II...Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe, Darren M. Kocs, Linda S. Couch
Journal of Thoracic Oncology. 2010-12-01 - Platelet dosing.Howard R Schlossberg, Jay H Herman
Transfusion and Apheresis Science. 2003-06-01 - 8 citationsSevere cutaneous ulceration following treatment with thalidomide for GVHD.H Schlossberg, Thomas R. Klumpp, P Sabol, Jay H. Herman, Mangan Kf
Bone Marrow Transplantation. 2001-01-01
